4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 新闻动态 >
热卖商品
新闻详情
...shareholder restructuring plan approved - Xinhua Silk Road
来自 : en.silkroad.news.cn/2018/1123/ 发布时间:2021-03-25

\"QQ截图20181123094807\"

BEIJING, Nov. 23 (Xinhua) -- The provincial government of East China\'s Jiangxi Province has approved JiangzhongPharmaceuticalGroup\'s strategic restructuring plan, according to an announcement released by Jiangzhong Pharmaceutical Co. Ltd (600750.SH).

According to the restructuring plan, China Resources Pharma Co., Ltd. will acquire a 51-percent stake in Jiangzhong PharmaceuticalGroup by capital increase and become its controlling shareholder.

After the transaction, the actual controller of the company will be China Resources Co., Ltd., and the ultimate actual controller will be the State-owned Assets Supervision and Administration Commission of the State Council, as China Resources Co., Ltd. is a centrally-administrated enterprise.(Edited by Bao Nuomin, baonuomin@xinhua.org)


Abstract : China Resources Pharma Co., Ltd. will acquire a 51-percent ...Do you want to be a contributor to Xinhua Silk Road and tell us your ...China-resources, jiangzhong-pharmaceutical-group,China Resources Pharma Co., Ltd. will acquire a 51-percent stake in Jiangzhong Pharmaceutical Group by capital increase and become its controlling shareholder.China JZJT's shareholder restructuring plan approved

本文链接: http://silkroadpharma.immuno-online.com/view-746008.html

发布于 : 2021-03-25 阅读(0)
公司介绍
品牌分类
联络我们
服务热线:4000-520-616
(限工作日9:00-18:00)
QQ :1570468124
手机:18915418616